Entries by CAPTIS

Insulet to Create Hundreds of Jobs in Massachusetts

BILLERICA, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced the Company has completed the acquisition of a facility in Acton, Massachusetts to establish a U.S. manufacturing location in the United States. “Insulet’s decision to purchase and operate a facility […]

How to Write the Best Cover Letter for a Research Scientist Job

February 16, 2017By Mark Terry, BioSpace.com Breaking News Staff There are generally three components to applying for a job—the cover letter, the resume or CV, and the actual interview. Each has a role, and they should work together. The cover letter grabs the interest of the recruiter, human resources executive or employer enough so they […]

Tired Of The U.S.? 6 Tips To Landing A Life Science Job Overseas

So you’ve decided you want to work in life sciences, but how can you take advantage of overseas opportunities? Hays’ Paul Strouts has the answers. The world is becoming smaller, it seems, with opportunities for working globally opening up like never before. This is particularly true in medicine and the life sciences sectors, which are […]

Hill-Rom completes acquisition of Mortara Instrument

Published 15 February 2017 Hill-Rom Holdings has completed its acquisition of Mortara Instrument for $330m in cash, primarily financed through a private offering of $300m of senior unsecured notes. Hill-Rom anticipates the structure of the acquisition will allow the company to qualify for a significant tax benefit, which at a net present value of approximately […]

Former Celgene and Medtronic CEOs Just Acquired This Maryland Biotech

February 14, 2017By Alex Keown, BioSpace.com Breaking News Staff GAITHERSBURG, Md. – Sol J. Barer, the former chief executive officer of Celgene (CELG) and current chairman of the board of Teva Pharmaceuticals (TEVA), and William Hawkins, former chairman and CEO of Medtronic (MDT), led a consortium of investors in the acquisition of Johns Hopkins University […]

Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech

February 13, 2017By Mark Terry, BioSpace.com Breaking News Staff Dublin-based Allergan (AGN) acquired Pleasanton, Calif.-based Zeltiq Aesthetics (ZLTQ) for $2.475 billion today. Zeltiq fits well into Allergan’s medical aesthetics portfolio. Zeltiq’s flagship product is CoolSculpting System, an FDA-cleared system that reduces unwanted fat using a patented cooling technology. It is considered a non-invasive alternative to […]